首页   按字顺浏览 期刊浏览 卷期浏览 Life-sustaining treatments in patients who died of chronic congestive heart failure com...
Life-sustaining treatments in patients who died of chronic congestive heart failure compared with metastatic cancer

 

作者: Tawee Tanvetyanon,   John Leighton,  

 

期刊: Critical Care Medicine  (OVID Available online 2003)
卷期: Volume 31, issue 1  

页码: 60-64

 

ISSN:0090-3493

 

年代: 2003

 

出版商: OVID

 

关键词: life-sustaining treatments;congestive heart failure;do-not-resuscitate order;metastatic cancer

 

数据来源: OVID

 

摘要:

IntroductionLife-sustaining treatments such as cardiopulmonary resuscitation, mechanical ventilation, vasopressors, and admission to critical care units, if used when recovery chance was remote, may unnecessarily cause discomfort and increase cost of care. Outcomes of these treatments in chronic, refractory congestive heart failure (CHF) and metastatic cancer patients were poor. Although both conditions were the leading causes of death, previous studies indicated that hospice utilization and do-not-resuscitate orders were less common in CHF patients. To date, the use of life-sustaining treatments in these patients and the influence of do-not-resuscitate orders remains unknown.MethodWe conducted a retrospective medical record review of the patients who died in our hospital in 1999 and had discharge diagnoses of CHF or cancer. Medical records were screened for seriously ill patients according to the modified SUPPORT criteria, which included patients with CHF functional class IV or ejection fraction of 20% or less at baseline and with metastatic cancer not receiving any curative treatments. Analyses were performed using SPSS, version 9.0.ResultsThere were 58 and 82 patients in CHF and cancer groups, respectively. CHF patients were older (78.8 vs. 67.3 yrs,p< .001) and stayed in the hospital longer (11.9 vs. 7.9 days,p= .014). The majority of patients in both groups received do-not-resuscitate orders before death (84% and 72%, respectively). CHF patients received do-not-resuscitate orders later than did cancer patients (6.7 vs. 2.8 days,p= .006). However, there was no significant difference in prevalence of do-not-resuscitate orders. All studied life-sustaining treatments were more common in CHF patients than in cancer patients. A subgroup analysis between CHF patients with do-not-resuscitate orders and those without do-not-resuscitate orders revealed cardiopulmonary resuscitation to be the only treatment less common in those with do-not-resuscitate orders.ConclusionsPatients who died of chronic, refractory CHF received more life-sustaining treatments than did patients who died of metastatic cancer.

 

点击下载:  PDF (200KB)



返 回